Aberrant expression of the integrin ITGA6, for example, was shown to affect cell–matrix interactions and cancer progression by the regulation of various signaling pathways such as PI3K/AKT or MEK/ERK [63,64,65,66,67]. The gene discussed is AKT1; the disease is cancer.